Matches in Wikidata for { <http://www.wikidata.org/entity/Q98720663> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q98720663 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98720663 description "scientific article published on 25 August 2020" @default.
- Q98720663 description "wetenschappelijk artikel" @default.
- Q98720663 description "наукова стаття, опублікована 25 серпня 2020" @default.
- Q98720663 name "Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib" @default.
- Q98720663 name "Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib" @default.
- Q98720663 type Item @default.
- Q98720663 label "Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib" @default.
- Q98720663 label "Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib" @default.
- Q98720663 prefLabel "Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib" @default.
- Q98720663 prefLabel "Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib" @default.
- Q98720663 P1433 Q98720663-15B5F567-C0F0-417A-93F8-FE3C825AB5F3 @default.
- Q98720663 P1476 Q98720663-9D3BD0AA-09FF-4858-A1A8-4FF762B2523D @default.
- Q98720663 P2093 Q98720663-1508A40F-5D63-4FE9-AAE2-298DC2380F44 @default.
- Q98720663 P2093 Q98720663-17C4F69C-D7B1-465A-80CF-5D0968FFCAC0 @default.
- Q98720663 P2093 Q98720663-4DDEF032-34C8-47D0-9361-BC3EFB6F9A84 @default.
- Q98720663 P2093 Q98720663-7F7D8F08-4544-4CC8-B5A8-4C5AE3BA0786 @default.
- Q98720663 P2093 Q98720663-87FA369D-8A7B-4D73-BA60-F08FCEF12E85 @default.
- Q98720663 P2093 Q98720663-A0164EEA-1420-4CF5-906F-ADE2BD1041FC @default.
- Q98720663 P2093 Q98720663-CBCFCCE8-7403-40BC-A9BF-145612DC2E62 @default.
- Q98720663 P2093 Q98720663-DCD5C59F-3BB5-4040-8CBD-C906D89176FC @default.
- Q98720663 P2093 Q98720663-F6E630A0-DD2D-4499-A747-09BC7DA8F4B4 @default.
- Q98720663 P31 Q98720663-01BDC652-C2BF-4B9A-B4F4-92875E67F571 @default.
- Q98720663 P356 Q98720663-AC714736-8097-40EB-8DDF-2722EED757C2 @default.
- Q98720663 P50 Q98720663-3C35F25C-07E1-418B-9236-92E9A6895A93 @default.
- Q98720663 P50 Q98720663-50F7AA65-3AF1-4857-A53E-C9F9AADF2C97 @default.
- Q98720663 P50 Q98720663-D34B25CE-065F-4BF6-A6A0-954ABC0C287D @default.
- Q98720663 P577 Q98720663-765C2AEF-714D-40F1-8A4F-990708EE5A30 @default.
- Q98720663 P698 Q98720663-9ADE601F-5F75-44D7-998C-3B4E19DEA734 @default.
- Q98720663 P921 Q98720663-18F979C6-6EEB-495B-9179-1442FDD93F19 @default.
- Q98720663 P932 Q98720663-2B3C0C20-CF3F-416D-9A41-0C971F243606 @default.
- Q98720663 P356 CAM4.3389 @default.
- Q98720663 P698 32841541 @default.
- Q98720663 P1433 Q27724564 @default.
- Q98720663 P1476 "Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib" @default.
- Q98720663 P2093 "Anna D Hrabovsky" @default.
- Q98720663 P2093 "Brittanie Millang" @default.
- Q98720663 P2093 "Imane El Dika" @default.
- Q98720663 P2093 "Jennifer Ma" @default.
- Q98720663 P2093 "Jinru Shia" @default.
- Q98720663 P2093 "Joanne F Chou" @default.
- Q98720663 P2093 "Marinela Capanu" @default.
- Q98720663 P2093 "Michele Ly" @default.
- Q98720663 P2093 "Richard K G Do" @default.
- Q98720663 P31 Q13442814 @default.
- Q98720663 P356 "10.1002/CAM4.3389" @default.
- Q98720663 P50 Q57517885 @default.
- Q98720663 P50 Q88923204 @default.
- Q98720663 P50 Q92901801 @default.
- Q98720663 P577 "2020-08-25T00:00:00Z" @default.
- Q98720663 P698 "32841541" @default.
- Q98720663 P921 Q18936 @default.
- Q98720663 P932 "7571806" @default.